Abstract
Involuntary abnormal movements have been reported after ischaemic and haemorrhagic stroke. Post stroke movement disorders can appear as acute or delayed sequel. At the moment, for many of these disorders the knowledge of pharmacological treatment is still inadequate. Dopaminergic and GABAergic systems may be mainly involved in poststroke movement disorders. This article provides a review on drugs commonly used in post-stroke movement disorders, given that some post-stroke movement disorders have shown a partial benefit with pharmacological approach.
Keywords: Post-stroke, movement disorders, hyperkinetic movements disorders, hypokinetic movements disorders, GABA, Dopamine, post-stroke recovery
Current Neuropharmacology
Title:Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Volume: 10 Issue: 3
Author(s): Antonio Siniscalchi, Luca Gallelli, Angelo Labate, Giovanni Malferrari, Caterina Palleria and Giovambattista De Sarro
Affiliation:
Keywords: Post-stroke, movement disorders, hyperkinetic movements disorders, hypokinetic movements disorders, GABA, Dopamine, post-stroke recovery
Abstract: Involuntary abnormal movements have been reported after ischaemic and haemorrhagic stroke. Post stroke movement disorders can appear as acute or delayed sequel. At the moment, for many of these disorders the knowledge of pharmacological treatment is still inadequate. Dopaminergic and GABAergic systems may be mainly involved in poststroke movement disorders. This article provides a review on drugs commonly used in post-stroke movement disorders, given that some post-stroke movement disorders have shown a partial benefit with pharmacological approach.
Export Options
About this article
Cite this article as:
Siniscalchi Antonio, Gallelli Luca, Labate Angelo, Malferrari Giovanni, Palleria Caterina and De Sarro Giovambattista, Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management, Current Neuropharmacology 2012; 10 (3) . https://dx.doi.org/10.2174/157015912803217341
DOI https://dx.doi.org/10.2174/157015912803217341 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroleptics and Migraine
Central Nervous System Agents in Medicinal Chemistry Promiscuous Beta-Strand Interactions and the Conformational Diseases
Current Medicinal Chemistry SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology Role of the Transglutaminase Enzymes in the Nervous System and their Possible Involvement in Neurodegenerative Diseases
Current Medicinal Chemistry Challenges with Mosquito-borne Viral Diseases: Outbreak of the Monsters
Current Topics in Medicinal Chemistry Anti-NMDA Receptor Encephalitis, Vaccination and Virus
Current Pharmaceutical Design Scrutinizing different EEG-Based Mechanisms for Motor Control and Rehabilitation of Lower Limb Disabilities
Neuroscience and Biomedical Engineering (Discontinued) Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Adult Stem Cell Transplants for Spinal Cord Injury Repair: Current State in Preclinical Research
Current Stem Cell Research & Therapy Radiation-Induced Neuroinflammation and Radiation Somnolence Syndrome
CNS & Neurological Disorders - Drug Targets The Potential Role of Functional Near-Infrared Spectroscopy as Clinical Biomarkers in Schizophrenia
Current Pharmaceutical Design Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems
Current Drug Targets Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia
Current Pharmaceutical Biotechnology Advances in Zebrafish High Content and High Throughput Technologies
Combinatorial Chemistry & High Throughput Screening Opioids, Sleep, and Sleep-Disordered Breathing
Current Pharmaceutical Design Imaging in Diabetic Retinopathy: A Review of Current and Future Techniques
Current Diabetes Reviews Inhibition of Protein Misfolding and Aggregation by Small Rationally-Designed Peptides
Current Pharmaceutical Design Aquaporin and Vascular Diseases
Current Neuropharmacology